Analysis of glaucoma market trends, growth opportunities and challenges, clinical activities, leading companies, emerging therapies and epidemiological forecasts

DelveInsight’s “Glaucoma Market” report offers an in-depth understanding of Nasopharyngeal Carcinoma (NPC), historical and forecasted epidemiology as well as Nasopharyngeal Carcinoma (NPC) market trends in US, EU5 (Germany, Spain , Italy, France, and United Kingdom) and Japan.

DelveInsight launched a new report on Glaucoma market Market Insights, Epidemiology and Forecast-2032”.

DelveInsight’s “Glaucoma Market Insights, Epidemiology, and Market Forecast-2032” report provides an in-depth understanding of glaucoma, historical and forecast epidemiology, and glaucoma market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

Some of the key facts from the Glaucoma Market report:

  • The total diagnosed prevalence of glaucoma in 7MM was estimated at 11,048,000 case in 2021
  • The total prevalent population diagnosed with open-angle glaucoma (OAG) and angle-closure glaucoma in the United States has been estimated to be 3,119,031 case and 346,559 case in 2021
  • In the United States, the highest number of glaucoma cases were in people over the age of 40, and the total number of cases was 3,168,213 Numbers
  • In the EU-5 region, the total diagnosed prevalence of glaucoma was highest in Germany with 1,115,113 cases followed by Italy with 965 487 case in 2021

Request a sample for the report:

Key benefits of the report:

  1. The Glaucoma Market report covers descriptive overview and comprehensive overview of Glaucoma and Glaucoma Epidemiology Market in 7MM (US, EU5 (Germany, Spain, France, Italy, UK) and Japan .)
  2. The Glaucoma Market report provides information on current and emerging therapies.
  3. The Glaucoma Market report provides historical and forecasted global market covering the diffusion of drugs in 7MM.
  4. The Glaucoma Market report provides an advantage which will help in developing business strategies by understanding the trends shaping and driving the Glaucoma Market.

You have questions ? Click here to learn more about the Glaucoma market landscape

Overview of Glaucoma:

Glaucoma is a disease that damages the optic nerve of the eye. It usually happens when fluid builds up in the front part of the eye. This extra fluid increases the pressure in the eye, damaging the optic nerve. The disease is one of the leading causes of blindness in people over 60. But blindness from glaucoma can often be prevented with early treatment. There are two main types of glaucoma, namely primary open-angle glaucoma (POAG) and angle-closure glaucoma/angle-closure glaucoma/angle-closure glaucoma.

Glaucoma is treated by lowering eye pressure (intraocular pressure) and, depending on the situation, management includes prescription eye drops, oral medications, laser treatment, surgery, or a combination of these. Traditionally, for newly diagnosed patients, treatment for glaucoma began with eye drops as first-line treatment options. In the case of patients who have encountered difficulty with eye drops, doctors move on to surgical options.

Glaucoma symptoms:

Glaucoma symptoms include-

  • severe headaches
  • pain in the eyes
  • Nausea and vomiting
  • Redness in the eyes
  • Blurred vision
  • See Halos around the lights
  • Vision loss

Glaucoma market

Glaucoma market dynamics are expected to change in the coming years owing to the expected launch of emerging therapies such as rhNGF, OPA-6566, JV-GL1 and others during the forecast period 2019-2032 .

Learn more by requesting a sample @Glaucoma market landscape

Glaucoma pipeline therapies:

  • rhNGF
  • Aflibercept
  • OPA-6566
  • AGN-193408 SR
  • EYEOP1
  • JV-GL1

Key Glaucoma Pipeline Companies:

  • Bayer
  • Kubota vision
  • Pharmaceutical Allysta
  • Otsuka Pharmaceutical
  • Regeneron Pharmaceuticals


1. Presentation of the report

2. Executive Summary

3. SWOT Analysis

4. Share of Glaucoma Patients (%) Overview at a Glance

5. Glaucoma Market Overview at a Glance

6. Background and Overview of Glaucoma Disease

7. Glaucoma epidemiology and patient population

8. Glaucoma Patient Population by Countries

9. Current Glaucoma Treatment and Medical Practices

10. Unmet Needs

11. Emerging Glaucoma Therapies

12. Glaucoma Market Outlook

13. Glaucoma Market Analysis by Countries (2018-2030)

14. Market Access and Reimbursement of Therapies

15. Market Drivers

16. Market Barriers

17. Appendix

18. Glaucoma Reporting Methodology

19. DelveInsight Abilities

20. Disclaimer

21. About DelveInsight

Click here to learn more about Glaucoma Market Outlook 2032

About DelveInsight

DelveInsight is a leading business consulting and market research firm focused exclusively on life sciences. It supports pharmaceutical companies by providing complete end-to-end solutions to improve their performance.

It also offers healthcare consulting services, which benefit from market analysis to accelerate business growth and overcome challenges with a hands-on approach.

Media Contact
Company Name: DelveInsight Business Research LLP
Contact person: Gaurav Bora
E-mail: Send an email
Call: +91 9568243403
Address:304 S. Jones Boulevard #2432
Town: Vegas
State: NV
Country: United States